New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
11:20 EDTRMTI, RMTI, AFFY, AFFY, KERX, KERX, AMAG, AMAGSummer Street's biotech research team holds analyst/industry conference call
Biotech Analyst Research Team, along with an MCRI consultant, discuss dialysis and iron products for end-state renal disorders on an Analyst/Industry conference call to be held on January 31 at 11:30 am.
News For RMTI;AFFY;KERX;AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
20:03 EDTAMAGAMAG Pharmaceuticals 3.15M share Secondary priced at $63.75
Jefferies and Barclays acted as joint book running managers for the offering.
08:29 EDTAMAGAMAG says 'additional insight' gained into FTC investigation
Subscribe for More Information
08:26 EDTAMAGAMAG capital raise removes overhang, says Leerink
Subscribe for More Information
July 29, 2015
17:15 EDTAMAGAMAG Pharmaceuticals announces proposed offering of $200M of common stock
Subscribe for More Information
10:41 EDTKERXOptions with increasing implied volatility
Subscribe for More Information
10:27 EDTKERXOptions with decreasing implied volatility
Subscribe for More Information
July 27, 2015
08:26 EDTKERXKeryx appoints Scott Holmes as CFO
Keryx Biopharmaceuticals announced the appointment of Scott A. Holmes to CFO effective immediately. Holmes will be responsible for Keryx's finance function and will be a member of the company's executive team. He will succeed James Oliviero whose planned departure was announced earlier this year. Oliviero will stay with the company through a transition period. Holmes brings nearly 20 years of life sciences and financial management expertise to Keryx. He joins the company from AMAG Pharmaceuticals where he most recently served as senior vice president, finance and investor relations during a period of high growth driven by acquisitions and public financings. Prior to AMAG, from 2009 to 2011, he was vice president of finance and treasurer of Molecular Biometrics.
July 24, 2015
07:13 EDTKERXKeryx receives CHMP positive opinion for Fexeric
Subscribe for More Information
July 23, 2015
10:00 EDTKERXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:13 EDTAMAGOn The Fly: Pre-market Movers
Subscribe for More Information
08:06 EDTKERXKeryx downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
07:25 EDTAMAGAMAG affirms FY15 revenue view $395M-$430M, consensus $465.45M
Raises FY15 adjusted EBITDA guidance view to $210M-$225M from $200M-$220M.
07:23 EDTAMAGAMAG reports Q2 adjusted EPS $1.12, one estimate $1.13
Subscribe for More Information
July 22, 2015
16:10 EDTAMAGAMAG acquires option for rights to Velo Bio's digoxin immune fab
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use